Publications by authors named "Cuncai Zhou"

Claim this Profile
A
Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006).
Xiaohui Duan, Dongde Wu, Cuncai Zhou, Yifeng Tian, Wenbin Duan

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous hepatectomy and splenectomy for patients with BCLC stage 0/A hepatocellular carcinoma and clinically significant portal hypertension: A multicenter retrospective cohort study.
Tianyin Shao, Hongwei Huang, Qi Cheng, Feng Xia, Zhanguo Zhang, Cuncai Zhou

Eur J Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese multicenter expert consensus on the diagnosis and treatment of hilar cholangiocarcinoma: 2025 edition.
Sulai Liu, Jinqiong Jiang, Qian Jian, Yingbin Liu, Zhiyong Huang, Cuncai Zhou, Feizhou Huang

Biosci Trends· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition).
Yu Yang, Juxian Sun, Mengchao Wu, Wan Yee Lau, Shusen Zheng, Jie Zhou, Cuncai Zhou, Jun Zhou, Ledu Zhou, Xinmin Zhou

Liver Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).
Juxian Sun, Rongping Guo, Xinyu Bi, Mengchao Wu, Zhaoyou Tang, Jie Zhou, Cuncai Zhou, Jian Zhou

Liver Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Jingyang Zhou, Jinhui Che, Lu Xu, Weizhong Yang, Wuyuan Zhou, Cuncai Zhou

Dig Liver Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Shukui Qin, Qiu Li, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Cuncai Zhou

Lancet Gastroenterol Hepatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of key miRNAs in the progression of hepatocellular carcinoma using an integrated bioinformatics approach.
Qi Zheng, Xiaoyong Wei, Jun Rao, Cuncai Zhou

PeerJ· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.
Guohui Xu, Xiaoyong Wei, Qiang Tu, Cuncai Zhou

Biosci Rep· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c[RGDyk]-coated liposomes loaded with adriamycin and miR-21 mimics inhibit the growth of hepatoma cell line SMCC-7721 via up-regulating Bax and p53.
Xiaoyong Wei, Xiaolong You, Jianlong Zhang, Cuncai Zhou

Transl Cancer Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR‑21 inhibitor facilitates the anticancer activity of doxorubicin loaded nanometer in melanoma.
Xiaoyong Wei, Xiaolong You, Jianlong Zhang, Cuncai Zhou

Oncol Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of sorafenib efficacy and safety in Chinese patients with high recurrence rate of post-hepatic carcinectomy.
Desheng Wang, Weridong Jia, Zhiming Wang, Tianfu Wen, Wei Ding, Cuncai Zhou

Onco Targets Ther· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Xiaoyong Wei, Xiaolong You, Jianlong Zhang, Cuncai Zhou

Mol Ther Nucleic Acids· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel use for the round ligament of the liver in a complicated bile duct operation.
Chang-He Zhang, Xing-Ye Yang, Xi Chen, Cun-Cai Zhou, Hong-Bing Zhou

ANZ J Surg· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dealing with the long and high biliary stricture.
Cun-cai Zhou, Xing-ye Yang, Chang-he Zhang, Xi Chen

ANZ J Surg· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder.
Yanhong Zheng, Cuncai Zhou, Yongchu Huang, Dingfang Bu, Xuejun Zhu

Int J Dermatol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis